Merck Share Holder Equity 2010-2024 | MKKGY
Merck share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
- Merck share holder equity for the quarter ending June 30, 2024 was $30.817B, a 5.56% increase year-over-year.
- Merck share holder equity for 2023 was $28.956B, a 5.68% increase from 2022.
- Merck share holder equity for 2022 was $27.399B, a 8.14% increase from 2021.
- Merck share holder equity for 2021 was $25.337B, a 30.35% increase from 2020.
Merck Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$28,956 |
| 2022 |
$27,399 |
| 2021 |
$25,337 |
| 2020 |
$19,439 |
| 2019 |
$20,064 |
| 2018 |
$20,352 |
| 2017 |
$15,899 |
| 2016 |
$15,548 |
| 2015 |
$14,266 |
| 2014 |
$15,687 |
| 2013 |
$14,703 |
| 2012 |
$13,394 |
| 2011 |
$14,617 |
| 2010 |
$ |
| 2009 |
$ |
Merck Quarterly Share Holder Equity
(Millions of US $) |
| 2024-06-30 |
$30,817 |
| 2024-03-31 |
$30,480 |
| 2023-12-31 |
$28,956 |
| 2023-09-30 |
$30,795 |
| 2023-06-30 |
$29,192 |
| 2023-03-31 |
$28,155 |
| 2022-12-31 |
$27,399 |
| 2022-09-30 |
$28,541 |
| 2022-06-30 |
$27,700 |
| 2022-03-31 |
$25,799 |
| 2021-12-31 |
$25,337 |
| 2021-09-30 |
$24,385 |
| 2021-06-30 |
$23,328 |
| 2021-03-31 |
$22,886 |
| 2020-12-31 |
$19,439 |
| 2020-09-30 |
$21,037 |
| 2020-06-30 |
$19,848 |
| 2020-03-31 |
$20,520 |
| 2019-12-31 |
$20,064 |
| 2019-09-30 |
$20,218 |
| 2019-06-30 |
$19,754 |
| 2019-03-31 |
$20,076 |
| 2018-12-31 |
$20,352 |
| 2018-09-30 |
$17,844 |
| 2018-06-30 |
$17,763 |
| 2018-03-31 |
$17,338 |
| 2017-12-31 |
$15,899 |
| 2017-09-30 |
$16,209 |
| 2017-06-30 |
$15,140 |
| 2017-03-31 |
$15,432 |
| 2016-12-31 |
$15,548 |
| 2016-09-30 |
$14,499 |
| 2016-06-30 |
$14,522 |
| 2016-03-31 |
$13,862 |
| 2015-12-31 |
$14,266 |
| 2015-09-30 |
$15,602 |
| 2015-06-30 |
$15,380 |
| 2015-03-31 |
$15,603 |
| 2014-12-31 |
$15,687 |
| 2014-09-30 |
$15,638 |
| 2014-06-30 |
$15,385 |
| 2014-03-31 |
$15,408 |
| 2013-12-31 |
$14,703 |
| 2013-09-30 |
$14,282 |
| 2013-06-30 |
$13,758 |
| 2013-03-31 |
$13,888 |
| 2012-12-31 |
$13,394 |
| 2012-09-30 |
$13,218 |
| 2012-06-30 |
$13,536 |
| 2012-03-31 |
|
| 2011-12-31 |
$14,617 |
| 2011-09-30 |
|
| 2011-06-30 |
$14,897 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
$13,586 |
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
